NCT06742125View on ClinicalTrials.gov

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With Premature ST-Segment Elevation Myocardial Infarction

NARecruitingINTERVENTIONAL
Enrollment

1,244

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions
ST-elevation Myocardial Infarction (STEMI)
Interventions
DEVICE

Drug-coated balloon (DCB)

Drug-coated balloon treatment of target lesions in patients with premature STEMI undergoing percutaneous coronary intervention.

DEVICE

Drug-eluting stent (DES)

Drug-eluting stent treatment of target lesions in patients with premature STEMI undergoing percutaneous coronary intervention.

Trial Locations (1)

Unknown

RECRUITING

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Peking University First Hospital

OTHER

collaborator

Suzhou Municipal Hospital

OTHER

collaborator

First Affiliated Hospital of Ningbo University

NETWORK

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06742125 - Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With Premature ST-Segment Elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter